MERIX PHARMACEUTICAL CORP.
Merix Pharmaceutical Corporation (“Merix”) is a privately owned U.S. corporation founded by inventor and biomedical researcher Meryl Squires. Since 1998, Merix has focused on the utilization of phyto-pharmaceutical technology specializing in the area of botanically derived antivirals that address contagious diseases.
Merix brought to market phyto-pharmaceutical treatments that had been invented by Ms. Squires through a proprietary process. Certain chemical compounds occurring naturally in plants are responsible for their color, organolepic, and medicinal properties. Ms. Squires believed long ago that phyto-chemicals have biological and medical significance.
Some of these natural plant compounds and their active constituents are known to have antimicrobial properties with the capability to affect pathogens as well as boost the human immune system lending traction in protecting the human body from contagious infection.
Merix is the exclusive source of the patented formulation Viracea® which comprises the proprietary Echinacea extract contained in the RELEEV® products. – The listed active ingredient in the RELEEV products is regulated by the FDA OTC Monograph system.
The listed active ingredient in the RELEEV products is regulated by the FDA OTC Monograph system.
The RELEEV products have been selling successfully as fast acting, highly efficacious treatments for numerous afflictions since 1998 and through some 35,000 retail stores across the USA today. These over the counter (‘OTC’) sales have to date been achieved without a coordinated internet presence.